An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Clinical trial NCT02557295 · TERMINATED

Trial details

NCT number: NCT02557295
Sponsor: Celltrion
Status: TERMINATED
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2013-12-17
Primary completion: 2020-03-02
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.